The cell and gene therapy market is exploding with medicinal products approved across multiple markets, with more products expected to receive regulatory approval in the upcoming years. Whilst all of these advancements are encouraging, a number of challenges remain in the manufacture of these transformative therapies especially as we look to move to commercial scale production.
Preparing for upscaling of cell and gene therapy products should be considered early during the product development to ensure success in the clinic and this includes streamlining manufacturing processes, sourcing raw materials, and QC for cell and gene therapy products.
Watch this On Demand webinar for the presentation featuring:
During this on demand, you’ll have the opportunity to hear the critical points to consider when designing a manufacturing process for your clinical cell and gene therapy products, including: